Efficacy and Safety of Anti-HER2 Targeted Therapy for Metastatic HR-Positive and HER2-Positive Breast Cancer: A Bayesian Network Meta-Analysis

Efficacy and Safety of Anti-HER2 Targeted Therapy for Metastatic HR-Positive and HER2-Positive Breast Cancer: A Bayesian Network Meta-Analysis

Despite the development of HER2-targeted drugs, achieving favorable outcomes for patients with HR+/HER2+MBC remains challenging. This study utilized Bayesian Network Meta-analysis to compare the efficacy and safety of anti-HER2 combination regimens. The primary analysis focused on progression-free s...

Full description

Bibliographic Details
Main Authors: Xian-Meng Wu, Yong-Kang Qian, Hua-Ling Chen, Chen-Hua Hu, Bing-Wei Chen
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Current Oncology
Subjects:
HR-positive
HER2-positive
metastatic breast cancer
targeted therapy
Bayesian network meta-analysis
Online Access:https://www.mdpi.com/1718-7729/30/9/615

Similar Items

Similar Items